Results 141 to 150 of about 1,724 (248)

Real time road scene classification and enhancement for driver assistance under adverse weather. [PDF]

Sci Rep
Anoop PP, Deivanathan R.
europepmc   +1 more source

Cardiovascular Outcomes in a SELECT‐Like Obesity Cohort: Real‐World Insights From the Swedish AROS Database

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8057-8071, September 2026.
ABSTRACT Background In the SELECT trial, semaglutide reduced major adverse cardiovascular outcomes (MACE) in individuals with overweight or obesity and established cardiovascular disease (CVD) but without diabetes. However, real‐world cardiovascular event rates in comparable populations remain uncharacterised.
Viveca Ritsinger, Josefine Fagerström, Håkan Nero, Thomas Cars, Maria K. Svensson, Anna Norhammar   +5 more
wiley   +1 more source

AttentionDriveNet: Fusion of deep cognitive network with Attention modeling for robust navigation in Self-driving vehicles. [PDF]

PLoS One
Mishra S, Mohata R, Tripathy HK, Mohanty JR, Sahoo KS, Jhanjhi NZ, Alourani A.   +6 more
europepmc   +1 more source

How the First 9 Months Shape the Rest of Your Life: The Impact of Gestational Diabetes on the Metabolic Future

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 7705-7718, September 2026.
ABSTRACT Gestational diabetes mellitus (GDM) represents far more than a transient glycaemic disorder: it is a sentinel metabolic event that unveils pre‐existing defects in β‐cell function and insulin action, with profound implications for both maternal and offspring cardiometabolic health across the lifespan.
Mustafa Kanat, Muhammad Abdul‐Ghani, Ralph A. DeFronzo   +2 more
wiley   +1 more source

Intrinsically stretchable all-polymer neuromorphic visual adaptive transistors based on multidimensional-phase-separation-induced micromesh. [PDF]

Nat Commun
Wang C, Qin M, Sun J, Bian Y, Zhu M, Shi W, Hong J, Cao Y, Liu Y, Zhao Z, Liu Y, Guo Y.   +11 more
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction‐Associated Steatotic Liver Disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8277-8287, September 2026.
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier, Ramon A. Hofmann, Michael Roden, Wolfgang Rathmann, Oliver Kuss   +4 more
wiley   +1 more source

Aerial video & trajectory dataset of vehicles on circular road. [PDF]

Data Brief
Riehl K, El-Baklish SK, Kouvelas A, Makridis MA.   +3 more
europepmc   +1 more source

Real‐World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8438-8451, September 2026.
ABSTRACT Aims To evaluate the real‐world effectiveness, safety and patient‐reported outcomes of biosynthetic semaglutide in adults with type 2 diabetes mellitus (T2DM) receiving routine outpatient care in a cost‐constrained setting. Methods This 30‐week, prospective, multicentre, non‐interventional study enrolled adults with T2DM initiating ...
Arshad Hussain, Muhammad Umar Wahab, Saleem Qureshi, Umar Yousaf Raja, Atif Munir, Shahnawaz Gardezi, Musarrat Iqbal, Bilal Afzal, Muhammad Daoud Butt, Siew Chin Ong   +9 more
wiley   +1 more source

Exploring pathways linking driving stress to self-regulation among older adults: A structural equation modeling approach using survey data. [PDF]

J Safety Res
Pae G, Davis J, Cavanaugh J, O'Neal E, Hamann C.   +4 more
europepmc   +1 more source

Politicized Framing of the Future: Encouraging Innovation in Mature Ecosystems in the Face of Asymmetric De Alio Entrants

Journal of Management Studies, Volume 63, Issue 6, Page 2894-2926, September 2026.
Abstract Hubs and participants of mature ecosystems increasingly compete with de alio entrants that are hubs of more innovative ecosystems. Prior research shows how these asymmetric de alio entrants frame to win over participants from mature ecosystems and suggests that hubs of these ecosystems should respond by encouraging innovation among ...
Georg Reischauer, Alexander Engelmann, Werner H. Hoffmann   +2 more
wiley   +1 more source